Predictors of Response for Elagolix with Add-back Therapy in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids
Further Publications UrologyFurther Publications Gynecology
Related content
Endometriosis
Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: 12 months of an ongoing randomized phase 3 trial
Am J Obstet Gynecol
Miller CE, Kim JH, Kroll R, Simon JA, Soliman AM, Thomas JW, Xu Y, Ng J, Snabes MC
doi: 10.1016/j.ajog.2024.06.040
Uro-Oncology
Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer: Analyses of the Randomized Phase 3 ARASENS Study
Eur Urol
Saad F, Hussain MHA, Tombal B, Fizazi K, Sternberg CN, Crawford ED, Nordquist LT, Bögemann M, Tutrone R, Shore ND, Belkoff L, Fralich T, Jhaveri J, Srinivasan S, Li R, Verholen F, Kuss I, Smith MR
doi: 10.1016/j.eururo.2024.03.036
Pregnancy and Childbirth
A randomised crossover design study comparing the pharmacokinetics and pharmacodynamics of two single Doses of ORal Aspirin (75 mg v 150mg) in pregnant women at risk of pre-eclampsia (DORA): implications on assessing aspirin response and patient adherence to therapy
Am J Obstet Gynecol
Vinogradov R, Kavanagh ON, Palmer J, Murphy P, Curtis E, Kamali F, Robson S
doi: 10.1016/j.ajog.2024.10.023
Pregnancy and Childbirth
Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial
Lancet Diabetes Endocrinol
Benhalima K, Beunen K, Van Wilder N, Ballaux D, Vanhaverbeke G, Taes Y, Aers XP, Nobels F, Marlier J, Lee D, Cuypers J, Preumont V, Siegelaar SE, Painter RC, Laenen A, Gillard P, Mathieu C
doi: 10.1016/S2213-8587(24)00089-5
Endometriosis
Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3)
Hum Reprod
Donnez J, Becker C, Taylor H, Carmona Herrera F, Donnez O, Horne A, Paszkowski M, Petraglia F, Renner SP, Patel A, Boolell M, Bestel E, Dolmans MM
doi: 10.1093/humrep/deae076
RECOMMENDED
Further Publications Gynecology
Long-Term Changes to Cardiovascular Biomarkers After Hormone Therapy in the Women's Health Initiative Hormone Therapy Clinical Trials
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Obstet Gynecol
Nudy M, Aragaki AK, Jiang X, Manson JE, Shadyab AH, Jung SY, Martin LW, Wild RA, Womack C, Mouton CP, Rossouw JE, Schnatz PF
doi: 10.1097/AOG.0000000000005862
Further Publications Gynecology
Short term outcomes of minimally invasive total versus supracervical hysterectomy for uterine fibroids: a NSQIP study
Am J Obstet Gynecol
Meyer R, Hamilton KM, Schneyer R, Levin G, Truong MD, Wright KN, Siedhoff MT
doi: 10.1016/j.ajog.2024.10.006
Pregnancy and Childbirth
Risk of postpartum hemorrhage according to the planned mode of delivery among pregnant women with one previous cesarean delivery: a secondary analysis of the Lower Uterine Segment Trial (LUSTrial)
Am J Obstet Gynecol
Boucherie AS, Quibel T, Thuillier C, Rozenberg P, Rousseau A
doi: 10.1016/j.ajog.2025.01.040
Further Publications Gynecology
Urinary microbiome community types associated with urinary incontinence severity in women
Am J Obstet Gynecol
Carnes MU, Siddiqui NY, Karstens L, Gantz MG, Dinwiddie DL, Sung VW, Bradley M, Brubaker L, Ferrando CA, Mazloomdoost D, Richter HE, Rogers RG, Smith AL, Komesu YM, Eunice Kennedy Shriver National Institute of Child Health and Human Development Pelvic Floor Disorders Network
doi: 10.1016/j.ajog.2023.10.036